Or was it 1974? By Laurie Gwen Shapiro One morning in the mid-1970s, a solemn announcement came over the intercom at Friends Seminary: “Noted person John Lennon is now in the meetinghouse.

Good day and welcome to the Stifel Financial fourth quarter financial results conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Stifel lowered the firm’s price target on Tesla (TSLA) to $474 from $492 and keeps a Buy rating on the shares. The firm cites the company’s “mixed” Q4 results, uncertainty caused by the ...

https://www.tipranks.com/news/the-fly/johnson-controls-price-target-raised-to-93-from-86-at-rbc-capital Stifel lowered the firm’s price target on Fastenal (FAST) to ...

(RTTNews) - Stifel Financial Corp. (SF) revealed earnings for its fourth quarter that increased from last year and beat the Street estimates. The company's earnings totaled $234.69 million ...

The gospel of John is dramatically different than the synoptic gospels (Matthew, Mark and Luke). Instead of organizing historical events into a chronology, John presents Jesus in all of his ...

September 5—John Baugh, Managing Director with Stifel Nicolaus, and Kemp Harr discuss John's research into the LVT flooring business. Listen to the interiew to hear more about how it's impacting ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...

John Travolta, just like Olivia Newton-John, skyrocketed to fame following the release of the film musical Grease in 1978, the year after he danced his way across the big screen in Saturday Night ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...